Literature DB >> 1323398

Partial benzodiazepine agonists in schizophrenia: expectations and present clinical findings.

A Delini-Stula1, D Berdah-Tordjman, N Neumann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1323398     DOI： 10.1097/00002826-199201001-00211

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  6 in total

Review 1.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

Review 2.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 3.  GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.

Authors:  Alessandro Guidotti; James Auta; John M Davis; Erbo Dong; Dennis R Grayson; Marin Veldic; Xianquan Zhang; Erminio Costa
Journal:  Psychopharmacology (Berl)       Date:  2005-04-28       Impact factor: 4.530

4.  Hippocampal benzodiazepine receptors in schizophrenia.

Authors:  G P Reynolds; D Stroud
Journal:  J Neural Transm Gen Sect       Date:  1993

5.  Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function.

Authors:  Justine Renard; Hanna J Szkudlarek; Cecilia P Kramar; Christina E L Jobson; Kyra Moura; Walter J Rushlow; Steven R Laviolette
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

Review 6.  Effects of Adolescent THC Exposure on the Prefrontal GABAergic System: Implications for Schizophrenia-Related Psychopathology.

Authors:  Justine Renard; Walter J Rushlow; Steven R Laviolette
Journal:  Front Psychiatry       Date:  2018-07-02       Impact factor: 4.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.